ロード中...
Prevalence of the metabolic syndrome in Luxembourg according to the Joint Interim Statement definition estimated from the ORISCAV-LUX study
BACKGROUND: The prevalence of the metabolic syndrome (MS) has been determined in many countries worldwide but never in Luxembourg. This research aimed to 1) establish the gender- and age-specific prevalence of MS and its components in the general adult population of Luxembourg, according to the most...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2011
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3024931/ https://ncbi.nlm.nih.gov/pubmed/21205296 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2458-11-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|